DOCSLIB.ORG

Supplemental Material

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplemental Material SUPPLEMENTAL MATERIAL Online OnlY Supplemental material miRNA expression profiling of cerebrospinal fluid in patients with cerebral aneurysmal subarachnoid hemorrhage S. S. Stylli et al. http://thejns.org/doi/abs/10.3171/2016.1.JNS151454 DisClaimer The Journal of Neurosurgery acknowledges that the following section is published verbatim as submitted by the authors and did not go through either the Journal’s peer-review or editing process. ©AANS, 2016 J Neurosurg Supplementary Table 1 nSolver Differential Expression Analysis Comparison Groups Comparison 1 No SAH SAH / No vasospasm (combined) CSF0012, CSF0018, CSF0030, CSF0034 CSF0020, CSF0023, CSF0024, CSF0025, CSF0038, CSF0039, CSF0040, CSF0041, CSF0042 Comparison 2 No SAH SAH / No vasospasm (Sample Day 1) CSF0012, CSF0018, CSF0030, CSF0034 CSF0020, CSF0023, CSF0024, CSF0027, CSF0041, CSF0038 Comparison 3 No SAH SAH / Vasospasm (combined) CSF0012, CSF0018, CSF0030, CSF0034 CSF0 022, CSF0027, CSF0032, CSF0033, CSF0036, CSF0044, CSF0045, CSF0048, CSF0052, CSF0053 Comparison 4 No SAH SAH / Vasospasm (Sample Day 1) CSF0012, CSF0018, CSF0030, CSF0034 CSF0027, CSF0032, CSF0036, CSF0044, CSF0052 Comparison 5 No SAH SAH / Vasospasm (post Sample Day 1) CSF0012, CSF0018, CSF0030, CSF0034 CSF0022, CSF0033, CSF0045, CSF0048, CSF0053 Comparison 6 SAH / No vasospasm (combined) SAH / Vasospasm (combined) CSF0020, CSF0023, CSF0024, CSF0025, CSF0022, CSF0027, CSF0032, CSF0033, CSF0036, CSF0038, CSF0039, CSF0040, CSF0041, CSF0044, CSF0045, CSF0048, CSF0052, CSF0053 CSF0042 Comparison 7 SAH / No vasospasm (Sample Day 1) SAH / Vasospasm (Sample Day 1) CSF0020, CSF0023, CSF0024, CSF0038, CSF0027, CSF0032, CSF0036, CSF0044, CSF0052 CSF0041 Comparison 8 SAH / No vasospasm (post Sample Day 1) SAH / vasospasm (post Sample Day 1) CSF0025, CSF0038, CSF0039, CSF0040, CSF0022, CSF0033, CSF0045, CSF0048, CSF0053 CSF0042 Supplementary Table 2 miRNA showing statistically significant fold level changes as determined by nSolver Analysis Software v2.6 Comparison 1 No SAH versus SAH / No vasospasm (combined) p-value Control Mean Case Mean Fold Change hsa-miR-451a* 0.0002 17.53 1262.2 72.01 hsa-miR-152* 0.0008 22.1 12.32 -1.79 hsa-miR-223-3p* 0.0009 9.81 28.94 2.95 hsa-miR-599* 0.0014 13.37 8.75 -1.53 hsa-miR-1224-3p* 0.0023 18.37 11.67 -1.57 hsa-miR-1301* 0.0036 13.73 8.24 -1.67 hsa-miR-548m* 0.0038 21.35 15.01 -1.42 hsa-miR-204-5p* 0.0045 13.43 42.28 3.15 hsa-miR-626* 0.0046 29.37 15.64 -1.88 hsa-miR-3180-5p* 0.0073 14.34 9.46 -1.52 hsa-miR-421* 0.0074 17.2 11.71 -1.47 hsa-miR-606* 0.0091 18.57 13 -1.43 hsa-miR-26a-5p* 0.0092 20.67 13.47 -1.53 hsa-miR-376c* 0.0097 17.1 11.62 -1.47 hsa-miR-3127-5p 0.0113 13.58 8.51 -1.6 hsa-miR-215 0.0179 30.85 19.23 -1.6 hsa-miR-1244 0.0254 34.11 23.91 -1.43 hsa-miR-580 0.0268 18.78 12.49 -1.5 hsa-miR-652-3p 0.027 12.13 8.24 -1.47 hsa-miR-452-5p 0.0291 12.7 6.85 -1.85 hsa-miR-521 0.0302 12.65 8.63 -1.47 hsa-miR-346 0.0359 20.2 11.63 -1.74 hsa-miR-510 0.0396 13.21 8.86 -1.49 hsa-miR-615-3p 0.0431 14.81 7.51 -1.97 hsa-miR-210 0.0432 16.03 10.56 -1.52 hsa-miR-485-5p 0.0454 18.94 12.16 -1.56 hsa-miR-144-3p 0.0465 25.77 66.32 2.57 Comparison 2 No SAH versus SAH / No vasospasm (Sample Day 1) p-value Control Mean Case Mean Fold Change hsa-miR-301a-3p* 0.0024 23.15 13.44 -1.72 hsa-miR-378d* 0.0087 18.44 7.94 -2.32 hsa-miR-596 0.0105 18.09 12.11 -1.49 hsa-miR-197-3p 0.0178 17.24 9.98 -1.73 hsa-miR-326 0.0207 10.29 4.43 -2.32 hsa-miR-576-3p 0.0258 15.07 24.64 1.64 hsa-miR-301b 0.0294 18.47 11 -1.68 hsa-miR-548y 0.0296 20.17 10.28 -1.96 hsa-miR-148b-3p 0.0324 18.65 12.2 -1.53 hsa-miR-890 0.0344 21.24 28.93 1.36 hsa-miR-370 0.0367 13.18 19.06 1.45 hsa-miR-486-3p 0.0369 20.56 12.88 -1.6 hsa-miR-4647 0.0405 19.59 12.51 -1.57 hsa-miR-3690 0.0443 21.96 13.52 -1.62 hsa-miR-1291 0.049 14.67 9.46 -1.55 hsa-miR-491-5p 0.0496 20.52 11.24 -1.83 Comparison 3 No SAH versus SAH / vasospasm (combined) p-value Control Mean Case Mean Fold Change hsa-miR-451a* 0.0005 19.26 1145.97 59.5 hsa-miR-937* 0.0006 20.27 11.19 -1.81 hsa-miR-519b-3p* 0.001 14.66 8.68 -1.69 hsa-miR-1224-3p* 0.0013 20.18 9.69 -2.08 hsa-miR-548m* 0.0014 23.46 14.3 -1.64 hsa-miR-1244* 0.0015 37.48 20.01 -1.87 hsa-miR-1301* 0.0018 15.08 8.78 -1.72 hsa-miR-2117* 0.0021 20.8 15.98 -1.3 hsa-miR-489* 0.0024 34.45 21.69 -1.59 hsa-miR-204-5p* 0.0034 14.75 41.16 2.79 hsa-miR-514b-3p* 0.0034 16.87 8.49 -1.99 hsa-miR-223-3p* 0.004 10.77 59.75 5.55 hsa-miR-521* 0.0044 13.9 7.99 -1.74 hsa-miR-624-3p* 0.0048 17.53 11.74 -1.49 hsa-miR-708-5p* 0.0052 11.86 6.75 -1.76 hsa-miR-508-3p* 0.0062 16.86 9.12 -1.85 hsa-miR-345-5p* 0.0073 17.63 9.39 -1.88 hsa-miR-137* 0.0077 18.83 10.74 -1.75 hsa-miR-599* 0.0077 14.69 7.71 -1.9 hsa-miR-4521* 0.0079 15.26 7.96 -1.92 hsa-miR-337-5p* 0.0089 21.18 17.09 -1.24 hsa-miR-320e* 0.0094 20.34 63.34 3.11 hsa-miR-346* 0.0095 22.19 13.43 -1.65 hsa-miR-152 0.0102 24.28 15.27 -1.59 hsa-miR-376c 0.011 18.79 14.85 -1.27 hsa-miR-198 0.0116 22.96 12.99 -1.77 hsa-miR-655 0.0118 18.89 8.15 -2.32 hsa-miR-580 0.0123 20.64 12.04 -1.71 hsa-miR-764 0.013 17.37 10.66 -1.63 hsa-miR-744-5p 0.0141 19.2 11.35 -1.69 hsa-miR-302a-3p 0.0177 13.69 10.37 -1.32 hsa-miR-548z 0.0189 29.2 19.87 -1.47 hsa-miR-485-5p 0.0196 20.81 11.99 -1.74 hsa-miR-548l 0.0201 15.28 11 -1.39 hsa-miR-548k 0.0202 24.2 15.79 -1.53 hsa-miR-328 0.0224 11.96 8.28 -1.44 hsa-miR-891a 0.0249 31.24 22.79 -1.37 hsa-miR-215 0.0262 33.89 24.02 -1.41 hsa-miR-4458 0.027 23.38 13.61 -1.72 hsa-miR-3147 0.0281 19.65 10.18 -1.93 hsa-miR-1277-3p 0.0284 21.41 13.34 -1.6 hsa-miR-26a-5p 0.0289 22.71 14.74 -1.54 hsa-miR-525-3p 0.0305 12.1 5.78 -2.1 hsa-miR-452-5p 0.0317 13.95 8.13 -1.72 hsa-miR-548c-5p 0.0324 21.73 14.63 -1.49 hsa-miR-765 0.0325 13.19 7.87 -1.68 hsa-miR-652-3p 0.0326 13.32 8.2 -1.62 hsa-miR-648 0.0332 15.93 8.43 -1.89 hsa-miR-615-3p 0.0339 16.27 9.39 -1.73 hsa-miR-649 0.0351 16.92 7.96 -2.13 hsa-miR-518e-3p 0.0356 9.78 6.06 -1.61 hsa-miR-519c-3p 0.0357 23.89 16.61 -1.44 hsa-miR-510 0.0365 14.51 9.28 -1.56 hsa-miR-516a-5p 0.0387 10.85 8.18 -1.33 hsa-miR-520h 0.0392 19.99 13.05 -1.53 hsa-miR-15a-5p 0.0398 19.36 27.22 1.41 hsa-miR-1281 0.0399 16.19 11.78 -1.37 hsa-miR-607 0.0402 16.82 8.06 -2.09 hsa-miR-133b 0.0418 15.77 12.3 -1.28 hsa-miR-146b-3p 0.042 12.5 8.43 -1.48 hsa-miR-421 0.0436 18.9 13.97 -1.35 hsa-miR-1303 0.0443 13.7 8.16 -1.68 hsa-miR-369-3p 0.0469 25.35 18.74 -1.35 hsa-miR-552 0.0469 15.84 10.83 -1.46 hsa-miR-596 0.0474 19.28 12.48 -1.55 hsa-miR-924 0.0475 13.91 10.51 -1.32 hsa-miR-1224-5p 0.0482 11.98 8.02 -1.49 hsa-miR-217 0.0488 39.9 26.6 -1.5 hsa-miR-320d 0.0492 12.6 8.43 -1.49 hsa-miR-626 0.0498 32.27 20.93 -1.54 hsa-miR-409-3p 0.0499 16.33 11.74 -1.39 Comparison 4 No SAH versus SAH / vasospasm (Sample Day 1) p-value Control Mean Case Mean Fold Change hsa-miR-548m* 0.0028 22.34 13.15 -1.7 hsa-miR-337-5p* 0.0056 20.17 16.68 -1.21 hsa-miR-519b-3p* 0.0078 13.96 8.06 -1.73 hsa-miR-764 0.0102 16.54 10.46 -1.58 hsa-miR-514b-3p 0.012 16.07 8.07 -1.99 hsa-miR-1301 0.019 14.36 8.91 -1.61 hsa-miR-204-5p 0.0195 14.05 45.58 3.24 hsa-miR-545-3p 0.0202 10.55 6.43 -1.64 hsa-miR-26a-5p 0.0226 21.63 15.02 -1.44 hsa-miR-3180-5p 0.0249 15.01 9.25 -1.62 hsa-miR-521 0.0272 13.24 7.02 -1.89 hsa-miR-599 0.0281 13.99 8.4 -1.67 hsa-miR-4448 0.0297 13.99 8.56 -1.63 hsa-miR-508-3p 0.0311 16.06 8.27 -1.94 hsa-miR-137 0.0346 17.93 12.2 -1.47 hsa-miR-525-3p 0.035 11.53 6.17 -1.87 hsa-miR-708-5p 0.035 11.3 5.93 -1.91 hsa-miR-23c 0.037 31.77 21.64 -1.47 hsa-miR-937 0.0408 19.31 12.05 -1.6 hsa-miR-1246 0.0442 1.12 1.03 -1.09 hsa-miR-1253 0.0442 1.12 1.03 -1.09 hsa-miR-1283 0.0442 1.12 1.03 -1.09 hsa-miR-143-3p 0.0442 1.12 1.03 -1.09 hsa-miR-1244 0.0457 35.69 23.56 -1.52 hsa-miR-451a 0.0463 18.34 722.04 39.37 hsa-miR-10b-5p 0.0483 13 6.74 -1.93 hsa-miR-146b-3p 0.0485 11.91 7.93 -1.5 hsa-miR-548q 0.0493 10.53 5.28 -1.99 hsa-miR-323a-5p 0.0498 12.9 8.27 -1.56 Comparison 5 No SAH versus SAH / vasospasm (post Sample Day 1) p-value Control Mean Case Mean Fold Change hsa-miR-489* 0.0007 33.41 17.31 -1.93 hsa-miR-548l* 0.0013 14.82 9.09 -1.63 hsa-miR-937* 0.003 19.66 9.81 -2 hsa-miR-302a-3p* 0.0038 13.28 8.22 -1.61 hsa-miR-1224-3p* 0.008 19.57 7.5 -2.61 hsa-miR-451a* 0.0093 18.68 2029.1 108.64 hsa-miR-345-5p* 0.0096 17.09 8.78 -1.95 hsa-miR-520h 0.0119 19.39 10.45 -1.86 hsa-miR-580 0.0165 20.01 10.74 -1.86 hsa-miR-320e 0.0172 19.72 82.09 4.16 hsa-miR-383 0.0177 16.03 11.4 -1.41 hsa-miR-548c-5p 0.018 21.08 12.23 -1.72 hsa-miR-1244 0.0184 36.35 16.03 -2.27 hsa-miR-1277-3p 0.0221 20.76 11 -1.89 hsa-miR-152 0.0229 23.55 13.58 -1.73 hsa-miR-1224-5p 0.0246 11.62 6.51 -1.78 hsa-miR-649 0.025 16.41 6.64 -2.47 hsa-miR-328 0.0254 11.6 7.21 -1.61 hsa-miR-2117 0.027 20.17 15.01 -1.34 hsa-miR-566 0.0275 21.66 13.9 -1.56 hsa-miR-409-3p 0.0278 15.84 9.38 -1.69 hsa-miR-4521 0.0292 14.8 5.69 -2.6 hsa-miR-378b 0.0302 21.54 13.24 -1.63 hsa-miR-508-3p 0.0318 16.36 9.49 -1.72 hsa-miR-1270 0.0322 16.51 10.81 -1.53 hsa-miR-624-3p 0.0338 17.01 9.61 -1.77 hsa-miR-496 0.0342 13.65 7.54 -1.81 hsa-miR-320d 0.0369 12.22 7.46 -1.64 hsa-miR-516a-5p 0.0381 10.52 7.03 -1.5 hsa-miR-655 0.0405 18.32 6.73 -2.72 hsa-miR-3147 0.0406 19.05 7.03 -2.71 hsa-miR-337-5p 0.0427 20.54 16.52 -1.24 hsa-miR-1301 0.0428 14.63 8.17 -1.79 hsa-miR-548m 0.0435 22.75 14.68 -1.55 hsa-miR-548k 0.0446 23.47 13.41 -1.75 hsa-miR-217 0.0447 38.7 23.66 -1.64 hsa-miR-215 0.0456 32.87 21.47 -1.53 hsa-miR-196b-5p 0.0462 16.51 8.54 -1.93 hsa-miR-708-5p 0.0462 11.51 7.25 -1.59 hsa-miR-421 0.0475 18.33 12.82 -1.43 hsa-miR-876-5p 0.0489 12.82 7.25 -1.77 hsa-miR-891a 0.0489 30.3 19.59 -1.55 hsa-miR-346 0.0492 21.52 13.28 -1.62 hsa-miR-133b 0.0493 15.3 10.44 -1.47
Load more

Recommended publications
  • FK506-Binding Protein 12.6/1B, a Negative Regulator of [Ca2+], Rescues Memory and Restores Genomic Regulation in the Hippocampus of Aging Rats
    This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. A link to any extended data will be provided when the final version is posted online. Research Articles: Neurobiology of Disease FK506-Binding Protein 12.6/1b, a negative regulator of [Ca2+], rescues memory and restores genomic regulation in the hippocampus of aging rats John C. Gant1, Eric M. Blalock1, Kuey-Chu Chen1, Inga Kadish2, Olivier Thibault1, Nada M. Porter1 and Philip W. Landfield1 1Department of Pharmacology & Nutritional Sciences, University of Kentucky, Lexington, KY 40536 2Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294 DOI: 10.1523/JNEUROSCI.2234-17.2017 Received: 7 August 2017 Revised: 10 October 2017 Accepted: 24 November 2017 Published: 18 December 2017 Author contributions: J.C.G. and P.W.L. designed research; J.C.G., E.M.B., K.-c.C., and I.K. performed research; J.C.G., E.M.B., K.-c.C., I.K., and P.W.L. analyzed data; J.C.G., E.M.B., O.T., N.M.P., and P.W.L. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. NIH grants AG004542, AG033649, AG052050, AG037868 and McAlpine Foundation for Neuroscience Research Corresponding author: Philip W. Landfield, [email protected], Department of Pharmacology & Nutritional Sciences, University of Kentucky, 800 Rose Street, UKMC MS 307, Lexington, KY 40536 Cite as: J. Neurosci ; 10.1523/JNEUROSCI.2234-17.2017 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published.
    [Show full text]
  • A Prelude to the Proximity Interaction Mapping of CXXC5
    www.nature.com/scientificreports OPEN A prelude to the proximity interaction mapping of CXXC5 Gamze Ayaz1,4,6*, Gizem Turan1,6, Çağla Ece Olgun1,6, Gizem Kars1, Burcu Karakaya1, Kerim Yavuz1, Öykü Deniz Demiralay1, Tolga Can2, Mesut Muyan1,3* & Pelin Yaşar1,5,6 CXXC5 is a member of the zinc-fnger CXXC family proteins that interact with unmodifed CpG dinucleotides through a conserved ZF-CXXC domain. CXXC5 is involved in the modulation of gene expressions that lead to alterations in diverse cellular events. However, the underlying mechanism of CXXC5-modulated gene expressions remains unclear. Proteins perform their functions in a network of proteins whose identities and amounts change spatiotemporally in response to various stimuli in a lineage-specifc manner. Since CXXC5 lacks an intrinsic transcription regulatory function or enzymatic activity but is a DNA binder, CXXC5 by interacting with proteins could act as a scafold to establish a chromatin state restrictive or permissive for transcription. To initially address this, we utilized the proximity-dependent biotinylation approach. Proximity interaction partners of CXXC5 include DNA and chromatin modifers, transcription factors/co-regulators, and RNA processors. Of these, CXXC5 through its CXXC domain interacted with EMD, MAZ, and MeCP2. Furthermore, an interplay between CXXC5 and MeCP2 was critical for a subset of CXXC5 target gene expressions. It appears that CXXC5 may act as a nucleation factor in modulating gene expressions. Providing a prelude for CXXC5 actions, our results could also contribute to a better understanding of CXXC5-mediated cellular processes in physiology and pathophysiology. Te methylation of mammalian genomic DNA, which predominantly arises post-replicatively at the 5’ posi- tion of the cytosine base in the context of CpG dinucleotides, varies across cell types, developmental stages, physiological and pathophysiological conditions 1.
    [Show full text]
  • A Specific FMNL2 Isoform Is Up-Regulated in Invasive Cells Christine Péladeau, Allan Heibein, Melissa T
    Péladeau et al. BMC Cell Biology (2016) 17:32 DOI 10.1186/s12860-016-0110-z RESEARCH ARTICLE Open Access A specific FMNL2 isoform is up-regulated in invasive cells Christine Péladeau, Allan Heibein, Melissa T. Maltez, Sarah J. Copeland and John W. Copeland* Abstract Background: Formins are a highly conserved family of cytoskeletal remodeling proteins. A growing body of evidence suggests that formins play key roles in the progression and spread of a variety of cancers. There are 15 human formin proteins and of these the Diaphanous-Related Formins (DRFs) are the best characterized. Included in the DRFs are the Formin-Like proteins, FMNL1, 2 & 3, each of which have been strongly implicated in driving tumorigenesis and metastasis of specific tumors. In particular, increased FMNL2 expression correlates with increased invasiveness of colorectal cancer (CRC) in vivo and for a variety of CRC cell-lines in vitro. FMNL2 expression is also required for invasive cell motility in other cancer cell-lines. There are multiple alternatively spliced isoforms of FMNL2 and it is predicted that the encoded proteins will differ in their regulation, subcellular localization and in their ability to regulate cytoskeletal dynamics. Results: Using RT-PCR we identified four FMNL2 isoforms expressed in CRC and melanoma cell-lines. We find that a previously uncharacterized FMNL2 isoform is predominantly expressed in a variety of melanoma and CRC cell lines; this isoform is also more effective in driving 3D motility. Building on previous reports, we also show that FMNL2 is required for invasion in A375 and WM266.4 melanoma cells. Conclusions: Taken together, these results suggest that FMNL2 is likely to be generally required in melanoma cells for invasion, that a specific isoform of FMNL2 is up-regulated in invasive CRC and melanoma cells and this isoform is the most effective at facilitating invasion.
    [Show full text]
  • Snapshot: Formins Christian Baarlink, Dominique Brandt, and Robert Grosse University of Marburg, Marburg 35032, Germany
    SnapShot: Formins Christian Baarlink, Dominique Brandt, and Robert Grosse University of Marburg, Marburg 35032, Germany Formin Regulators Localization Cellular Function Disease Association DIAPH1/DIA1 RhoA, RhoC Cell cortex, Polarized cell migration, microtubule stabilization, Autosomal-dominant nonsyndromic deafness (DFNA1), myeloproliferative (mDia1) phagocytic cup, phagocytosis, axon elongation defects, defects in T lymphocyte traffi cking and proliferation, tumor cell mitotic spindle invasion, defects in natural killer lymphocyte function DIAPH2 Cdc42 Kinetochore Stable microtubule attachment to kinetochore for Premature ovarian failure (mDia3) chromosome alignment DIAPH3 Rif, Cdc42, Filopodia, Filopodia formation, removing the nucleus from Increased chromosomal deletion of gene locus in metastatic tumors (mDia2) Rac, RhoB, endosomes erythroblast, endosome motility, microtubule DIP* stabilization FMNL1 (FRLα) Cdc42 Cell cortex, Phagocytosis, T cell polarity Overexpression is linked to leukemia and non-Hodgkin lymphoma microtubule- organizing center FMNL2/FRL3/ RhoC ND Cell motility Upregulated in metastatic colorectal cancer, chromosomal deletion is FHOD2 associated with mental retardation FMNL3/FRL2 Constituently Stress fi bers ND ND active DAAM1 Dishevelled Cell cortex Planar cell polarity ND DAAM2 ND ND ND Overexpressed in schizophrenia patients Human (Mouse) FHOD1 ROCK Stress fi bers Cell motility FHOD3 ND Nestin, sarcomere Organizing sarcomeres in striated muscle cells Single-nucleotide polymorphisms associated with type 1 diabetes
    [Show full text]
  • Autophagic Digestion of Leishmania Major by Host Macrophages Is
    Frank et al. Parasites & Vectors (2015) 8:404 DOI 10.1186/s13071-015-0974-3 RESEARCH Open Access Autophagic digestion of Leishmania major by host macrophages is associated with differential expression of BNIP3, CTSE, and the miRNAs miR-101c, miR-129, and miR-210 Benjamin Frank1, Ana Marcu1, Antonio Luis de Oliveira Almeida Petersen2,3, Heike Weber4, Christian Stigloher5, Jeremy C. Mottram2, Claus Juergen Scholz4 and Uta Schurigt1* Abstract Background: Autophagy participates in innate immunity by eliminating intracellular pathogens. Consequently, numerous microorganisms have developed strategies to impair the autophagic machinery in phagocytes. In the current study, interactions between Leishmania major (L. m.) and the autophagic machinery of bone marrow-derived macrophages (BMDM) were analyzed. Methods: BMDM were generated from BALB/c mice, and the cells were infected with L. m. promastigotes. Transmission electron microscopy (TEM) and electron tomography were used to investigate the ultrastructure of BMDM and the intracellular parasites. Affymetrix® chip analyses were conducted to identify autophagy-related messenger RNAs (mRNAs) and microRNAs (miRNAs). The protein expression levels of autophagy related 5 (ATG5), BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3), cathepsin E (CTSE), mechanistic target of rapamycin (MTOR), microtubule-associated proteins 1A/1B light chain 3B (LC3B), and ubiquitin (UB) were investigated through western blot analyses. BMDM were transfected with specific small interfering RNAs (siRNAs) against autophagy-related genes and with mimics or inhibitors of autophagy-associated miRNAs. The infection rates of BMDM were determined by light microscopy after a parasite-specific staining. Results: The experiments demonstrated autophagy induction in BMDM after in vitro infection with L.
    [Show full text]
  • Identification of the Binding Partners for Hspb2 and Cryab Reveals
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity.
    [Show full text]
  • Integrative Analysis Reveals RNA G-Quadruplexes in Utrs Are Selectively Constrained and Enriched for Functional Associations
    ARTICLE https://doi.org/10.1038/s41467-020-14404-y OPEN Integrative analysis reveals RNA G-quadruplexes in UTRs are selectively constrained and enriched for functional associations David S.M. Lee 1, Louis R. Ghanem 2* & Yoseph Barash 1,3* G-quadruplex (G4) sequences are abundant in untranslated regions (UTRs) of human messenger RNAs, but their functional importance remains unclear. By integrating multiple 1234567890():,; sources of genetic and genomic data, we show that putative G-quadruplex forming sequences (pG4) in 5’ and 3’ UTRs are selectively constrained, and enriched for cis-eQTLs and RNA-binding protein (RBP) interactions. Using over 15,000 whole-genome sequences, we find that negative selection acting on central guanines of UTR pG4s is comparable to that of missense variation in protein-coding sequences. At multiple GWAS-implicated SNPs within pG4 UTR sequences, we find robust allelic imbalance in gene expression across diverse tissue contexts in GTEx, suggesting that variants affecting G-quadruplex formation within UTRs may also contribute to phenotypic variation. Our results establish UTR G4s as important cis-regulatory elements and point to a link between disruption of UTR pG4 and disease. 1 Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 2 Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, The Children’s Hospital of Philadelphia and The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. 3 Department
    [Show full text]
  • Transcriptional Regulation of RKIP in Prostate Cancer Progression
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Sciences Transcriptional Regulation of RKIP in Prostate Cancer Progression Submitted by: Sandra Marie Beach In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Sciences Examination Committee Major Advisor: Kam Yeung, Ph.D. Academic William Maltese, Ph.D. Advisory Committee: Sonia Najjar, Ph.D. Han-Fei Ding, M.D., Ph.D. Manohar Ratnam, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: May 16, 2007 Transcriptional Regulation of RKIP in Prostate Cancer Progression Sandra Beach University of Toledo ACKNOWLDEGMENTS I thank my major advisor, Dr. Kam Yeung, for the opportunity to pursue my degree in his laboratory. I am also indebted to my advisory committee members past and present, Drs. Sonia Najjar, Han-Fei Ding, Manohar Ratnam, James Trempe, and Douglas Pittman for generously and judiciously guiding my studies and sharing reagents and equipment. I owe extended thanks to Dr. William Maltese as a committee member and chairman of my department for supporting my degree progress. The entire Department of Biochemistry and Cancer Biology has been most kind and helpful to me. Drs. Roy Collaco and Hong-Juan Cui have shared their excellent technical and practical advice with me throughout my studies. I thank members of the Yeung laboratory, Dr. Sungdae Park, Hui Hui Tang, Miranda Yeung for their support and collegiality. The data mining studies herein would not have been possible without the helpful advice of Dr. Robert Trumbly. I am also grateful for the exceptional assistance and shared microarray data of Dr.
    [Show full text]
  • Effect of Chromosomal Copy Number Variations on Congenital Birth Defects and Human Developmental Disorders
    EFFECT OF CHROMOSOMAL COPY NUMBER VARIATIONS ON CONGENITAL BIRTH DEFECTS AND HUMAN DEVELOPMENTAL DISORDERS APPROVED BY SUPERVISORY COMMITTEE Andrew R. Zinn, M.D., Ph.D Christine K. Garcia, M.D., Ph.D Orson Moe, M.D., Ph.D Ralph DeBerardinis, M.D., Ph.D DEDICATION Many many people have given me love, support, advice, and caffeine over the course of my graduate research to which I am eternally grateful. To Andrew, my mentor for many years and scientific guide- if someday I become half the researcher you are, I will have turned out. There aren’t enough words- thank you, thank you, thank you. To my thesis committee- thank for your insightful comments, direction and criticism and most for your genuine desire to see me succeed. To my collaborators, Vidu Garg and Linda Baker- thank you for sharing your research with a lowly grad student. I would literally have nothing to research without your generosity. To the lab-thanks for listening to boring mitochondrial results each week. I will miss you terribly. To Miguel- No puedo poner a las palabras la profundidad de mi amor para usted. Usted es mi amigo, mi amor, mi corazón, mi amante, mi ayuda y mi ancla. Con usted por mi lado puedo lograr las cosas magníficas que no podría solamente. Te amo. To Justin- the talk of complex four late at night was worth it. Love you. To Kim, Kristen and Adriane- my absolute favorite people- thank you for believing even when I did not. Thank you for listening to me when I needed it most.
    [Show full text]
  • Autophagy -   Autophagy
    EMBO Molecular Medicine cross-journal focus Autophagy - Autophagy EDITORS Andrea Leibfried Editor [email protected] | T + Andrea worked with Jan Lohmann on stem cell maintenance in the plant Arabidopsis before moving to the eld of trafcking. In she obtained her PhD from the Université Pierre et Marie Curie in Paris, for which she studied DE-Cadherin trafcking in Drosophila with Yohanns Bellaiche at the Curie Institute. She then went to Anne Ephrussi’s lab at the EMBL in Heidelberg to work on oocyte polarity and mRNA trafcking in Drosophila. Andrea joined The EMBO Journal in . Nonia Pariente Senior Editor [email protected] | T + Nonia joined EMBO Reports in August . She studied biochemistry and molecular biology in Madrid’s Autónoma University, where she also gained her PhD on the generation of new antiviral strategies against RNA viruses. She did a four-year post-doc at UCLA focusing on the development of new strategies for gene therapy. Céline Carret Editor [email protected] | T + Céline Carret completed her PhD at the University of Montpellier, France, characterising host immunodominant antigens to ght babesiosis, a parasitic disease caused by a unicellular EMBO Apicomplexan parasite closely related to the malaria agent Plasmodium. She further developed Molecular her post-doctoral career on malaria working at the Wellcome Trust Sanger Institute in Cambridge, Medicine UK and Instituto de Medicina Molecular in Lisbon, Portugal. Céline joined EMBO Molecular Medicine as a Scientic Editor in March . Maria Polychronidou Editor [email protected] | T + Maria received her PhD from the University of Heidelberg, where she studied the role of nuclear membrane proteins in development and aging.
    [Show full text]
  • EGFR Phosphorylation of DCBLD2 Recruits TRAF6 and Stimulates AKT-Promoted Tumorigenesis
    The Journal of Clinical Investigation RESEARCH ARTICLE EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis Haizhong Feng,1,2 Giselle Y. Lopez,3 Chung Kwon Kim,2 Angel Alvarez,2 Christopher G. Duncan,3 Ryo Nishikawa,4 Motoo Nagane,5 An-Jey A. Su,6 Philip E. Auron,6 Matthew L. Hedberg,7 Lin Wang,7 Jeffery J. Raizer,2 John A. Kessler,2 Andrew T. Parsa,8 Wei-Qiang Gao,1 Sung-Hak Kim,9 Mutsuko Minata,9 Ichiro Nakano,9 Jennifer R. Grandis,7 Roger E. McLendon,3 Darell D. Bigner,3 Hui-Kuan Lin,10 Frank B. Furnari,11 Webster K. Cavenee,11 Bo Hu,2 Hai Yan,3 and Shi-Yuan Cheng1,2 1State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 2Department of Neurology and Northwestern Brain Tumor Institute, Center for Genetic Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 3Pediatric Brain Tumor Foundation Institute at Duke, The Preston Robert Tisch Brain Tumor Center, and Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA. 4Department of Neuro-Oncology/Neurosurgery, International Medical Center, Saitama Medical University, Saitama, Japan. 5Department of Neurosurgery, Kyorin University, Tokyo, Japan. 6Department of Biological Sciences, Duquesne University, Pittsburgh, Pennsylvania, USA. 7Departments of Otolaryngology and Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. 8Department of Neurological Surgery and Northwestern Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
    [Show full text]
  • Open Dogan Phdthesis Final.Pdf
    The Pennsylvania State University The Graduate School Eberly College of Science ELUCIDATING BIOLOGICAL FUNCTION OF GENOMIC DNA WITH ROBUST SIGNALS OF BIOCHEMICAL ACTIVITY: INTEGRATIVE GENOME-WIDE STUDIES OF ENHANCERS A Dissertation in Biochemistry, Microbiology and Molecular Biology by Nergiz Dogan © 2014 Nergiz Dogan Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy August 2014 ii The dissertation of Nergiz Dogan was reviewed and approved* by the following: Ross C. Hardison T. Ming Chu Professor of Biochemistry and Molecular Biology Dissertation Advisor Chair of Committee David S. Gilmour Professor of Molecular and Cell Biology Anton Nekrutenko Professor of Biochemistry and Molecular Biology Robert F. Paulson Professor of Veterinary and Biomedical Sciences Philip Reno Assistant Professor of Antropology Scott B. Selleck Professor and Head of the Department of Biochemistry and Molecular Biology *Signatures are on file in the Graduate School iii ABSTRACT Genome-wide measurements of epigenetic features such as histone modifications, occupancy by transcription factors and coactivators provide the opportunity to understand more globally how genes are regulated. While much effort is being put into integrating the marks from various combinations of features, the contribution of each feature to accuracy of enhancer prediction is not known. We began with predictions of 4,915 candidate erythroid enhancers based on genomic occupancy by TAL1, a key hematopoietic transcription factor that is strongly associated with gene induction in erythroid cells. Seventy of these DNA segments occupied by TAL1 (TAL1 OSs) were tested by transient transfections of cultured hematopoietic cells, and 56% of these were active as enhancers. Sixty-six TAL1 OSs were evaluated in transgenic mouse embryos, and 65% of these were active enhancers in various tissues.
    [Show full text]